Investment Firm Adds Nearly $4 Million in DYN Shares
A major investment firm boosted its Dyne Therapeutics stake by nearly $4 million, highlighting renewed interest in DY...
Poor planning undermines budget success; explore effective forecasting, set realistic goals, and implement steady review to keep your finances on course.
21,840 articlesA major investment firm boosted its Dyne Therapeutics stake by nearly $4 million, highlighting renewed interest in DY...
Connecticut lawmakers introduced Senate Bill 340 to require public marketing of most 1-4 unit residential listings, w...
A long-stalled crypto bill in Congress shows little traction after Trump’s social media post. TD Cowen notes that pre...
A sharp 36% February drop put Lemonade in the spotlight. This guide breaks down what happened, how the AI-driven grow...
A major gaming operator dominates the spotlight with $11.5 billion in revenue, while a $16 million institutional exit...
The U.S. and Gulf states have pressed Kyiv for access to Ukraine’s interceptor tech as Western stocks of high-cost mi...
Micron Technology races higher on AI memory demand and supply tightness. This piece outlines why investors may consid...
Netflix has shown strong momentum, but a stock price path hinges on more than business strength. This article breaks ...
The year 2025 saw disaster costs ease, yet losses exceeded $100 billion four times in five years. Insurers remain cau...
Salesforce plans up to $25 billion in debt to fund an accelerated share repurchase that would buy back roughly 14% of...
Oil jolts can rattle markets fast. This guide explains why oil spikes matter for stocks, what history shows, and acti...
As Mach Natural Resources (MNR) reports Q4 2025 results, investors should focus on cash flow, capital allocation, and...